Vraylar 1.5 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DR26FQ96V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,361
Award facts
- Contract value 100% obligated
- $32,360.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $32,361 to AmerisourceBergen Drug Corp for the supply of Vraylar 1.5 mg capsules (30-count units) on November 17, 2025, with completion scheduled for November 18, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order as a child contract under its larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs.
Vraylar, a neurological treatment medication, represents one of numerous pharmaceutical products that AmerisourceBergen supplies to federal customers through its expansive portfolio of delivery orders with the DLA. The contractor's federal contract awards demonstrate consistent capability in meeting defense medical procurement requirements across multiple therapeutic domains, including diabetes medications, specialty pharmaceuticals, vaccines, and medical supplies. Through its prime indefinite delivery vehicle, AmerisourceBergen provides critical medical commodities to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems on a global basis.
Quick answers
Who was awarded contract SPE2DR26FQ96V?
SPE2DR26FQ96V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FQ96V worth?
The government has obligated $32,361 on SPE2DR26FQ96V.
Is contract SPE2DR26FQ96V an order under another contract?
Yes. SPE2DR26FQ96V is a delivery order under SPE2DR25D2003, an indefinite delivery contract.
Was contract SPE2DR26FQ96V competed?
The extent of competition for SPE2DR26FQ96V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award